C139H185FN20O15 — CID 157386955
N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(1-methylazetidin-3-yl)oxy-3-pyridinyl]benzamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(4-methyl-1,4-diazepan-1-yl)-3-pyridinyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[3-fluoro-4-[(4-hydroxypiperidin-1-yl)methyl]phenyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[6-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide (PubChem CID 157386955) has the molecular formula C139H185FN20O15 and a molecular weight of 2395.13 g/mol. Its IUPAC name is N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(1-methylazetidin-3-yl)oxy-3-pyridinyl]benzamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(4-methyl-1,4-diazepan-1-yl)-3-pyridinyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[3-fluoro-4-[(4-hydroxypiperidin-1-yl)methyl]phenyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[6-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide.
| Compound Name | N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(1-methylazetidin-3-yl)oxy-3-pyridinyl]benzamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(4-methyl-1,4-diazepan-1-yl)-3-pyridinyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[3-fluoro-4-[(4-hydroxypiperidin-1-yl)methyl]phenyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[6-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide |
|---|---|
| PubChem CID | 157386955 |
| Molecular Formula | C139H185FN20O15 |
| Molecular Weight | 2395.13 g/mol |
| Exact Mass | 2393.43 |
| IUPAC Name | N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(1-methylazetidin-3-yl)oxy-3-pyridinyl]benzamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[6-(4-methyl-1,4-diazepan-1-yl)-3-pyridinyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[3-fluoro-4-[(4-hydroxypiperidin-1-yl)methyl]phenyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide;3-[ethyl(oxan-4-yl)amino]-5-[6-[(4-hydroxypiperidin-1-yl)methyl]-3-pyridinyl]-2-methyl-N-[(6-methyl-2-oxo-4-propan-2-yl-1H-pyridin-3-yl)methyl]benzamide |
| SMILES | CCN(c1cc(-c2ccc(CN3CCC(O)CC3)c(F)c2)cc(C(=O)NCc2c(C(C)C)cc(C)[nH]c2=O)c1C)C1CCOCC1.CCN(c1cc(-c2ccc(CN3CCC(O)CC3)nc2)cc(C(=O)NCc2c(C(C)C)cc(C)[nH]c2=O)c1C)C1CCOCC1.CCN(c1cc(-c2ccc(N3CCCN(C)CC3)nc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1.CCN(c1cc(-c2ccc(OC3CN(C)C3)nc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1 |
| InChI | InChI=1S/C37H49FN4O4.C36H49N5O4.C34H46N6O3.C32H41N5O4/c1-6-42(29-11-15-46-16-12-29)35-20-28(26-7-8-27(34(38)19-26)22-41-13-9-30(43)10-14-41)18-32(25(35)5)36(44)39-21-33-31(23(2)3)17-24(4)40-37(33)45;1-6-41(29-11-15-45-16-12-29)34-19-27(26-7-8-28(37-20-26)22-40-13-9-30(42)10-14-40)18-32(25(34)5)35(43)38-21-33-31(23(2)3)17-24(4)39-36(33)44;1-6-40(28-10-16-43-17-11-28)31-20-27(26-8-9-32(35-21-26)39-13-7-12-38(5)14-15-39)19-29(25(31)4)33(41)36-22-30-23(2)18-24(3)37-34(30)42;1-6-37(25-9-11-40-12-10-25)29-15-24(23-7-8-30(33-16-23)41-26-18-36(5)19-26)14-27(22(29)4)31(38)34-17-28-20(2)13-21(3)35-32(28)39/h7-8,17-20,23,29-30,43H,6,9-16,21-22H2,1-5H3,(H,39,44)(H,40,45);7-8,17-20,23,29-30,42H,6,9-16,21-22H2,1-5H3,(H,38,43)(H,39,44);8-9,18-21,28H,6-7,10-17,22H2,1-5H3,(H,36,41)(H,37,42);7-8,13-16,25-26H,6,9-12,17-19H2,1-5H3,(H,34,38)(H,35,39) |
| InChIKey | BLNXHPXCRWZVIW-UHFFFAOYSA-N |
| XLogP | 19.31 |
| TPSA | 402.28 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 175 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2395.13 |
| LogP ≤ 5 | 19.31 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 27 |